title: Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
abstract: Neuroleptic malignant syndrome (NMS) is the most serious of acute neurological side effects produced by antipsychotic medication, characterized by hyperthermia, rigidity, altered consciousness and autonomic dysfunction, the prevalence of which varies from 0.4-1.4%. NMS is usually seen in treatment with high potency typical antipsychotics and very rarely with atypical antipsychotics. However, NMS cases have been reported with risperidone, clozapine, olanzapine and quetiapine. The presentations of NMS have often varied and we report another atypicality in presentation of NMS due to olanzapine use.
authors.affiliation: Dept. of Psychiatry, Central Institute of Psychiatry, Ranchi, India.
authors.forename: Biswaranjan
authors.initials: B
authors.lastname: Mishra
authors.forename: Baikunthanath
authors.initials: B
authors.lastname: Mishra
authors.forename: Saddichha
authors.initials: S
authors.lastname: Sahoo
authors.forename: Manu
authors.initials: M
authors.lastname: Arora
authors.forename: C R J
authors.initials: CR
authors.lastname: Khess
mesh_terms: D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine